Bard PowerPort removal surgery is usually the first hard cost a patient faces after an implanted port fails. The PowerPort is a small chemotherapy port placed under the skin of the chest or arm. When the attached catheter cracks, fractures, or migrates, surgeons typically must take the device out. Thousands of patients report exactly that outcome. As a result, federal courts consolidated the claims into one multidistrict litigation in Arizona. This guide explains what removal and revision care involves, and what a claim may cover.
Complete a short case review to see whether your diagnosis, Bard PowerPort implant history, and records may fit current attorney screening criteria. Submitting information does not guarantee representation, compensation, or participation in any lawsuit or settlement.
What Is the Bard PowerPort Removal Surgery Litigation About?
The Bard PowerPort is an implantable venous access device. Doctors use it to deliver chemotherapy, antibiotics, and contrast dye. It spares patients repeated needle sticks. C.R. Bard designed and sold the device. Becton, Dickinson and Company acquired Bard in 2017 and is a co-defendant. Millions of ports have been implanted in the United States over the past two decades.
Plaintiffs allege a material defect in the catheter tubing. The tubing blends polyurethane with barium sulfate, a contrast agent that makes the line visible on imaging. Lawsuits claim the barium sulfate particles do not bond evenly. Over time, the surface allegedly degrades and weakens. However, the plaintiffs say Bard never adequately warned doctors or patients about that risk.
Reported injuries include catheter fracture, migration of broken fragments, bloodstream infection, deep vein thrombosis, cardiac arrhythmia, and vessel perforation. The FDA MAUDE adverse event database holds thousands of reports involving Bard port catheters. Bard PowerPort removal surgery becomes necessary in many of these cases. For example, a fractured fragment that travels to the heart may require an interventional radiology retrieval procedure on top of the explant.
| Type of Care | What It Typically Involves | Cost Note |
|---|---|---|
| Routine port explant | Outpatient, 20–40 minutes, local anesthesia | Published price-transparency data lists prices starting near $1,800 |
| Complicated explant | Scar tissue, adhesions, retained cuff, operating room time | Varies; often several times a routine removal |
| Fragment retrieval | Endovascular snare retrieval in a cath lab | Varies widely by hospital and length of stay |
| Revision / replacement port | New device placed at a different site | Varies; separate charge from removal |
| Infection treatment | IV antibiotics, sepsis admission, ICU in severe cases | Varies; hospitalization drives most of the cost |
Case Timeline
Last checked: July 23, 2026
- July 01, 2026 (Case Status): More than 3,300 cases remain pending in MDL 3081, with the next bellwether trial, the first involving a catheter fracture claim, set for August 18, 2026, and no global settlement reached. (Court Record)
- May 08, 2026 (Ruling): The jury in the first bellwether returned a defense verdict for Bard and Becton Dickinson on failure to warn, failure to instruct, and consumer fraud, but deadlocked on the design defect claim. (Court Record)
- April 21, 2026 (Bellwether Date): The first bellwether trial, Cook v. C.R. Bard/Becton Dickinson, an infection case, began before Judge Campbell in Phoenix. (Court Record)
- August 08, 2023 (Other): The JPML centralized federal Bard implanted port catheter lawsuits as MDL No. 3081 in the U.S. District Court for the District of Arizona before Judge David G. Campbell. (Court Record)
MDL Case Status and Key Facts
| Item | Detail |
|---|---|
| MDL number | MDL No. 3081, In re: Bard Implanted Port Catheter Products Liability Litigation |
| Presiding judge | Senior U.S. District Judge David G. Campbell |
| Federal district | U.S. District Court for the District of Arizona (Phoenix) |
| Consolidated | August 2023 by the Judicial Panel on Multidistrict Litigation |
| Approximate pending cases | Roughly 3,400–3,600 as of mid-2026 |
| First bellwether | Tried May 2026; partial defense verdict, hung jury on design defect |
| Next trials | August 18, 2026; then October 13, December 1, and February 2027 |
The Judicial Panel on Multidistrict Litigation publishes updated case counts each month. An MDL is not a class action. Each plaintiff keeps a separate case with individual damages. In most cases, the court tries a handful of representative “bellwether” claims first. Those results help both sides value the remaining inventory.
The first bellwether involved an infection injury. The jury sided with Bard on failure to warn but deadlocked on design defect. Trial lawyers now watch the August 2026 case closely. Typically, fracture claims present clearer physical evidence than infection claims. A documented Bard PowerPort removal surgery that recovered a broken catheter fragment gives a jury something tangible to see.
Who Qualifies for a Bard PowerPort Removal Surgery Claim?
Eligibility generally starts with device identification. You need proof that a Bard or Becton Dickinson port was implanted. Covered product lines include the PowerPort, PowerPort ClearVUE, PowerPort isp, PowerPort Duo, PowerPort MRI, and SlimPort models. Implant dates in these cases generally run from the early 2000s through the present. However, older records can be hard to obtain.
The second element is a qualifying injury. Firms filing in this MDL typically look for catheter fracture, device migration, thrombosis or blood clot, bloodstream or port-site infection, sepsis, cardiac arrhythmia, tissue necrosis, or vessel damage. A Bard PowerPort removal surgery performed because of one of those complications is central proof. Routine end-of-treatment removals do not qualify on their own.
Evidence matters more than memory. Useful records include the implant operative report, the device sticker or lot number, imaging that shows the fracture, and the explant operative note. Pathology or device retention records help too. As a result, patients who ask the hospital to preserve the removed device are in a stronger position. A licensed attorney can send records requests on your behalf.
How to File a Bard PowerPort Removal Surgery Claim
Start by consulting a licensed attorney who handles medical device litigation. Most work on contingency, so an initial review costs nothing. The lawyer will screen your implant records and injury history. If the case fits, they file a short-form complaint directly into MDL 3081 under Judge Campbell’s direct-filing order. That avoids a separate transfer step through the JPML.
Every plaintiff then completes a Plaintiff Fact Sheet. This is a sworn questionnaire covering medical history, implant details, treating providers, and damages. Deadlines are firm. Missing them can lead to dismissal. Your Bard PowerPort removal surgery records, billing statements, and imaging all get attached as supporting exhibits.
Watch the statute of limitations. Product liability deadlines are set by state law and commonly run two to four years. Some states apply a discovery rule, which starts the clock when you learn the device caused the harm. Cornell’s Legal Information Institute explains the general concept. Because the rules vary, do not guess. Ask an attorney promptly.
Settlement Updates and What to Expect
No global settlement exists in MDL 3081 as of July 2026. No class action fund is paying claims. Anyone promising a fixed payout is not describing reality. Defendants rarely negotiate broadly until several bellwether verdicts land. Trials are scheduled through February 2027, so the picture should sharpen over the next year.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Compensation categories, if a case resolves, typically include past and future medical bills, lost wages, reduced earning capacity, pain and suffering, and in some states punitive damages. The cost of a Bard PowerPort removal surgery and any revision procedure falls squarely in the medical damages category. Amounts vary case by case. You may qualify for recovery, but nothing is guaranteed.
Several factors influence value. Injury severity ranks first. A sepsis admission or open-heart fragment retrieval carries more weight than an uncomplicated explant. Documentation quality, the strength of causation testimony, your age, and your state’s damage caps all matter. Cases without a Bard PowerPort removal surgery or clear imaging tend to be valued lower.
State-by-State Considerations
State law governs damages even inside a federal MDL. Under the Erie doctrine, the transferee court applies the substantive law of the plaintiff’s home state. Texas, for example, caps non-economic damages in some contexts and has a strong compliance defense. California allows broad recovery and has no general cap in product cases. Florida enacted tort reform in 2023 that shortened its negligence limitations period.
Arizona, as the MDL forum, hosts the trials but does not supply the governing law for out-of-state plaintiffs. New York and Pennsylvania both contribute large filing volumes, partly because of their dense cancer-treatment centers. Illinois and Ohio also show notable counts. A Bard PowerPort removal surgery performed in one state, after an implant in another, can raise a genuine choice-of-law question. Discuss it with a licensed attorney.
Frequently Asked Questions
Does my port have to be removed before I can file a claim?
Not always, but it helps significantly. Documented explant or revision surgery is the clearest evidence of device failure. However, patients with imaging-confirmed fractures who are too ill for surgery may still have a claim. An attorney can evaluate your specific records.
Will a claim cover the cost of my removal and replacement port?
Medical expenses are a standard damages category in these cases. That typically includes the removal, any fragment retrieval, hospitalization, and a replacement device. Keep every bill and explanation of benefits. Health insurers and Medicare may assert liens against any recovery.
Has Bard recalled the PowerPort?
No. As of July 2026, there has been no recall tied to catheter material degradation, despite hundreds of adverse event reports filed with the FDA. A recall is not required to bring a product liability claim. You might be eligible even though the device remains on the market.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
- DOJ: justice.gov — settlement announcements and press releases
- FDA: fda.gov — drug recalls, warning letters, and safety alerts
- CDC: cdc.gov — health condition data and exposure guidelines
- EPA: epa.gov — environmental contamination data
- Cornell LII: law.cornell.edu — plain-English legal definitions
Content last reviewed July 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- Pennsylvania Tort Reform Guide
- Georgia Tort Reform Guide
- New Jersey Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.
Complete a short case review to see whether your diagnosis, Bard PowerPort implant history, and records may fit current attorney screening criteria. Submitting information does not guarantee representation, compensation, or participation in any lawsuit or settlement.
Important: Legal deadlines can be time sensitive and vary by state, diagnosis date, exposure history, and other facts. Submitting information through this website does not file a lawsuit, preserve your rights, create an attorney-client relationship, or guarantee that any attorney will contact or represent you. If you do not receive a response, or if you are unsure about a filing deadline, you should promptly contact a qualified attorney of your choice to discuss your specific situation.
About this page: MassTortInfo.com is an informational publishing platform and a marketing / referral platform. We are not a law firm, settlement administrator, claims administrator, or government agency, and we do not provide legal advice. No attorney-client relationship is created by using this site or submitting any form. Submitting a form does not guarantee representation, compensation, eligibility, or participation in any lawsuit or settlement. This page contains paid advertising, and we may be compensated if you submit a case review. See our Terms of Service, Privacy Policy, and Disclaimer & Advertising Disclosure.